-
Mashup Score: 1
Le service de cardiologie du CHPG vient d’obtenir le label « Centre d’Excellence Européen Hypertension Artérielle ». C’est une reconnaissance mais aussi un atout précieux pour développer ses activités, comme nous l’explique le chef du service, le professeur Atul Pathak, qui est, par ailleurs, président de la Société Française de l’Hypertension Artérielle.
Categories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Effect of Discontinuing vs Continuing ACEIs and ARBs in Patients Admitted With COVID-19 - 4 year(s) ago
This randomized clinical trial compares the effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs) on days alive and out of the hospital at 30 days among patients with COVID-19 taking the drugs prior to hospitalization.
Source: jamanetwork.comCategories: Cardiologists, Latest HeadlinesTweet-
Effect of Discontinuing vs Continuing ACEIs and ARBs in Patients Admitted With COVID-19 https://t.co/7iAFFl7jZc via @JAMA_current part of @JAMANetwork . Étude qui rappelle qu’on n’arrête pas les IEC ou ARA 2 chez les patients hospitalisés pour la COVID.
-
-
Mashup Score: 0
Abstract Background Tricuspid regurgitation (TR) is a frequent disease with a progressive increase in mortality as disease severity increases. Transcatheter therapies for treatment of TR may offer …
Categories: Cardiologists, Latest HeadlinesTweet-
Transcatheter Edge-to-Edge Repair for Treatment of Tricuspid Regurgitation: https://t.co/W4CmxOWtEG finally an option for patients difficult to manage them. How many received a mineraloreceptor antagonist? @PhilippLurz
-
-
Mashup Score: 212-Month Results From the Unblinded Phase of the RADIANCE-HTN SOLO Trial of Ultrasound Renal Denervation - 4 year(s) ago
This study reports the 12-month results of the RADIANCE-HTN (A Study of the ReCor Medical Paradise System in Clinical Hypertension) SOLO trial followi…
Source: www.sciencedirect.comCategories: Cardiologists, Latest HeadlinesTweet-
12-Month Results From the Unblinded Phase of the RADIANCE-HTN SOLO Tri... https://t.co/U8LHBAEXQf really disappointing this loss of effect at 12 months on BP reduction in a real world setting. Let’s wait for the TRIO results and data from competitor. End of story?
-
-
Mashup Score: 0Un capteur pour suivre à distance les insuffisants cardiaques - La Gazette de Monaco - 5 year(s) ago
Première à Monaco mais aussi en région PACA : la pose hier vendredi d’un nouveau capteur sans fil implanté de manière mini-invasive dans l’artère pulmonaire de patients insuffisants cardiaques. Le service de cardiologie du CHPG a en effet décidé de proposer une toute nouvelle solution qui permet aux patients d’être suivis à distance. Ce système […]
Source: La Gazette de MonacoCategories: Cardiologists, Latest HeadlinesTweet-
Un capteur pour suivre à distance les insuffisants cardiaques - La Gazette de Monaco @hopitalMonaco merci à notre Hôpital de son soutien. Vive Monaco et leur envie de toujours innover. https://t.co/M8b54GAMli
-
-
Mashup Score: 81Chloroquine : dans The Lancet, une étude contredit gravement les affirmations du Pr Raoult - 5 year(s) ago
Bonjour 22/05/2020. Que répondra-t-il ? C’est une publication d’importance que vient de diffuser, sans embargo, The Lancet : « Hydroxychloroquine or chloroquine with or without a mac…
Source: Journalisme et Santé PubliqueCategories: Cardiologists, Latest HeadlinesTweet-
RT @jynau: Chloroquine : The Lancet publie un travail accablant contredisant les affirmations du Pr Raoult https://t.co/xucfNxLDA2
-
-
Mashup Score: 6
Brazil lost its second health minister in a month on Friday after President Jair Bolsonaro demanded wider use of unproven anti-malarial drugs to fight the coronavirus outbreak, adding to turmoil in one of the pandemic’s worst global hotspots.
Source: U.S.Categories: Cardiologists, Latest HeadlinesTweet-
RT @hansijzerman: And the question is when the French academy is going to investigate Raoult: https://t.co/MKMG4TEfOk. Any chance that will…
-
-
Mashup Score: 187Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial - 5 year(s) ago
Objective To assess the efficacy and safety of hydroxychloroquine plus standard of care compared with standard of care alone in adults with coronavirus disease 2019 (covid-19). Design Multicentre, open label, randomised controlled trial. Setting 16 government designated covid-19 treatment centres in China, 11 to 29 February 2020. Participants 150 patients admitted to hospital with laboratory…
Source: The BMJCategories: Cardiologists, Latest HeadlinesTweet-
RT @EricTopol: 2 new #COVID19 hydroxychloroquine trials, one randomized: no go https://t.co/FzUuGK3Qfc https://t.co/fgEiQgYhKg @bmj_latest…
-
-
Mashup Score: 12
Le Pr Pathak explique comment l’hypertension artérielle peut être un marqueur de population à risque, rappelle le rôle du système rénine-angiotensine et les signes à surveiller chez les hypertendus durant l’épidémie.
Source: MedscapeCategories: Cardiologists, Latest HeadlinesTweet-
Une session sur l'hypertension et COVID 19 avec les amis et experts du CJH @CJH_HTA @sfhta @SFCardio @sfhta @FZores @f_mouquet @pabeda1 @AngoulvantD @SABOURETCardio https://t.co/YTPSbxQs0Q
-
-
Mashup Score: 1Clinical Trials Register - 5 year(s) ago
E.1 Medical condition or disease under investigation E.1.1Medical condition(s) being investigated Patients with documented respiratory infection with coronavirus SARS COV 2 E.1.1.1Medical condition in easily understood language Patients with coronavirus disease COVID-19 E.1.1.2Therapeutic area Diseases [C] – Virus Diseases [C02] MedDRA Classification E.1.3Condition being studied…
Source: www.clinicaltrialsregister.euCategories: Cardiologists, Latest HeadlinesTweet-
RT @Matadon_: @raoult_didier On en parle de modifier les outcomes à l'envi ? https://t.co/3ZaOjFB9rC https://t.co/sDRBsAaYtE
-
Le CHPG, Centre d’Excellence Européen en Hypertension - La Gazette de Monaco https://t.co/3XIomJ168T via @GazettedeMonaco